Sandra and Edward Meyer Cancer Center

News

Irene Min, Ph.D.

2017 Apr 02

Cell therapy provides shot at a cure for fatal thyroid cancer

In the first demonstration of the potential for CAR-T therapy for previously untreatable advanced thyroid cancers, researchers from the Meyer Cancer Center were able to eliminate cancerous cells in cultures and mice. Read more

Photo of Dr Andrew Dannenberg

2017 Apr 01

Women with healthy BMI may have increased risk of breast cancer

Women with a healthy body mass index (BMI) may be at risk of developing breast cancer because of enlarged fat cells in their breast tissue that trigger an inflammatory process, according to Andrew Dannenberg, M.D. Read more

Kaitlyn Gayvert

2017 Apr 01

Toxic targets: Saving lives in silico

A computational tool created by graduate students predicts how people’s livers, hearts and other tissues might respond to different drugs, in order to ID potentially dangerous side effects before the drugs are tested in people. Read more

Ekta Khurana, Ph.D.

2017 Mar 31

Shedding a light on "dark matter" data

Ekta Khurana, Ph. D., assistant professor of computational genomics has created a computational tool that can mine terabytes of overlooked genomic data to uncover potentially unknown drivers of cancer. Read more

Adrienne Phillips, M.D.

2017 Mar 30

Health conditions that disproportionately affect black women

Adrienne Phillips, M.D., discusses some cancers and blood disorders that are prevalent in black women. Read more

2017 Mar 23

Study to focus on breast cancer link to bone metastasis

Ithaca associate Claudia Fischbach-Teschl, Ph.D., has secured more than $1 million in funding from the Human Frontier Science Program (HFSP) to study breast cancer’s effect on the mineralization pathways in bone. Read more

2017 Mar 22

Why Trump’s N.I.H. cuts should worry us

A substantial N.I.H. budget cut would undermine the fiscal stability of universities and medical schools, many of which depend on N.I.H. funding; it would erode America’s leadership in medical research; and it would diminish opportunities to discover new ways to prevent and treat diseases, argues Harold Varmus, M.D. Read more

Dr Mark Rubin

2017 Mar 22

Three-pronged approach key to precision medicine

Patient-derived organoids are allowing researchers and clinicians to take precision medicine to the next level, according to a new paper by Mark Rubin and Lewis Cantley. Read more

Sandra Allen-Bard, MSN, ANCC, AOCNP

2017 Mar 21

We Are Weill Cornell Medicine: Sandy Allen-Bard

Profile of nurse practitioner Sandy Allen-Bard, a star of the Weill Cornell Leukemia Program. Read more

Felice Schnoll-Sussman, M.D.

2017 Mar 21

Can you hear me now?

Felice Schnoll-Sussman, M.D., discusses how to approach the colonoscopy conversation with a patient. Read more

David Lyden, M.D., Ph.D.

2017 Mar 15

Sohn Foundation funds pediatric cancer research

David Lyden and Haiying Zhang received two grants from the Sohn Conference Foundation to advance their investigation into how cancer spreads in children. Read more

prostate oganoids

2017 Mar 13

Research Reveals Gene Mutation as Driver of Prostate Cancer Subtype

A newly discovered genetic mutation that is found in a subtype of prostate cancer is integral to the disease’s development and growth, according to research from Weill Cornell Medicine scientists . Their findings could pave... Read more

Mirjam Blattner, Ph.D.

2017 Mar 13

Research reveals gene mutation as driver of prostate cancer subtype

A research team led by Mark Rubin and Chris Barbieri found that the SPOP mutation leads to prostate cancer that grows in a distinctively different way from other common subtypes. Read more

Broadway actress Karen Walsh got creative during treatment for colon cancer at Weill Cornell Medicine

2017 Mar 12

Broadway actress and colon cancer patient Karen Walsh uses theatrical skills to raise awareness

Broadway actress Karen Walsh's creative response to her colon cancer treatment has inspired others. Read more

Richard Silver, M.D.

2017 Mar 09

Cancer pill Gleevec keeps patients alive and well for a decade

Richard Silver, M.D., discusses the success of Gleevac, the once-a-day pill that has turned chronic myelogenous leukemia, or CML, from a certain death sentence into a manageable disease. Read more

microscopic image of prostate cancer

2017 Mar 07

Department of Defense Impact Award Funds Prostate Cancer Study

Weill Cornell Medicine researchers will receive a grant from the Department of Defense to conduct an in-depth study of the molecular machinery driving the most aggressive form of prostate cancer. Most prostate cancers are a... Read more

Kristen McRedmond, stage IV colon cancer warrior

2017 Mar 07

Kristen was the picture of health. She died of colorectal cancer at 38

Felice Schnoll-Sussman, M.D., discusses colon cancer among the young, including her inspirational patient, Kristen McRedmond. Read more

David Rickman, Ph.D.

2017 Mar 07

Department of Defense Impact Award funds prostate cancer study

David Rickman and Himisha Beltran will receive a grant from the Department of Defense to conduct an in-depth study of N-Myc and the molecular machinery driving neuroendocrine prostate cancer. Read more

2017 Mar 03

Dr. Virginia Pascual Named Director of the Gale and Ira Drukier Institute for Children’s Health

NEW YORK (March 3, 2017) — Dr. Virginia Pascual, a renowned physician-scientist specializing in pediatric rheumatology, has been appointed the founding Gale and Ira Drukier Director of the Gale and Ira Drukier Institute for... Read more

2017 Mar 01

The first cell inspired a career of genomic discoveries & cancer research

Profile of geneticist Christopher Mason, Ph.D. Read more